Find the latest clinical trials by condition, location & phase
Browse and search for drug information and related clinical trials
Explore a comprehensive list of organizations, including their profiles and details.
Latest updates on clinical trials, pharmaceuticals, and healthcare companies
Stay informed with timely notifications on clinical trials and research advancements.
No overview information available.
No background information available.
No indication information available.
No associated conditions information available.
ReAlta Life Sciences will present new clinical data from its Phase 2 STAR trial investigating RLS-0071 (pegtarazimod) for hypoxic ischemic encephalopathy (HIE) in newborns at the Pediatric Academic Societies 2025 Meeting.
The complement inhibitors market is experiencing growth due to increased understanding of the complement system's role in rare and chronic diseases.
ReAlta Life Sciences has initiated a Phase 2 clinical trial of RLS-0071 for steroid-refractory acute graft-versus-host disease (aGvHD).